GENE ONLINE|News &
Opinion
Blog

Trials & Approvals
Trials & Approvals Type 1 Diabetes
Canadian Regulators Give Go-Ahead for Diabetes Trial Using CRISPR, ViaCyte’s Gene-Edited Stem Cell-Derived Therapy
2021-11-16
Trials & Approvals Cardiac Disease
Moderna, AstraZeneca Tout Encouraging Trial Data for mRNA-Based Therapeutic in Cardiac Health
2021-11-16
Trials & Approvals Blood Cancer
FDA Approves First Interferon Therapy for Rare Blood Cancer
2021-11-15
Trials & Approvals CAR T-cell Therapy
Considering Manufacturing and Commercial Advantages, Poseida Makes Strategic Shift Towards Allogeneic CAR-T Products
2021-11-10
Trials & Approvals Migraine
Amgen Announces Encouraging Full Data for Migraine Drug, Aimovig
2021-11-09
Trials & Approvals Obesity
Novo Nordisk’s Weight Loss Drug Shines in Phase 3 Trial
2021-11-07
Trials & Approvals Alzheimer's Disease
Cortexyme’s Shares Implode after Alzheimer’s Disease Drug Flunks Trial
2021-10-29
Trials & Approvals Cancer
AstraZeneca’s Imfinzi Beats Standard of Care in Advanced Biliary Tract Cancer
2021-10-26
Trials & Approvals Dupixent
Sanofi, Regeneron’s Dupixent Shines in Phase 3 Trial for Prurigo Nodularis
2021-10-25
Trials & Approvals CRISPR
Intellia’s CRISPR Drug Claims FDA Orphan Drug Designation to Treat ATTR Amyloidosis
2021-10-22
Trials & Approvals Gene Therapy
Sio Gene Therapies Touts Positive Safety and Biomarker Data for GM1 Gangliosidosis Candidate
2021-10-22
Trials & Approvals Depression
Biogen, Sage Pursue 2022 Filing for Depression Therapy, Zuranolone
2021-10-20
Trials & Approvals Nasal Spray
Oyster Point’s Nasal Spray for Dry Eyes Notches FDA Approval
2021-10-19
Trials & Approvals Amyotrophic Lateral Sclerosis
Biogen’s ALS Drug Fails to Attain Primary Endpoint but Offers Hope With Secondary Outcomes
2021-10-18
Trials & Approvals
AstraZeneca’s Imfinzi, Tremelimumab Combo Significantly Improves Overall Survival in Phase 3 Trials
2021-10-18
1 … 23 24 25 26 27 … 50
LATEST
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
READ MORE
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top